Hyperthermic intraperitoneal chemotherapy for treatment of ovarian and primary peritoneal cancer: single institutional experience

Andikyan, Vaagn

432
Hyperthermic intraperitoneal chemotherapy for treatment of ovarian and primary peritoneal cancer: single institutional experience

Sunday, March 29, 2015: 7:00 AM

Salon C-D (Hilton Chicago)

V. Andikyan¹, P. Tabrizian², S. Farag², J. Fields¹, V. Kolev³, J. Rahaman², D. A. Fishman², U. Sarpel², K. Zakashansky¹ and D. Labow²
¹Icahn School of Medicine at Mount Sinai, New York, NY, ²Mount Sinai School of Medicine, New York, NY, ³Beth Israel Medical Center, New York, NY

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

432
Hyperthermic intraperitoneal chemotherapy for treatment of ovarian and primary peritoneal cancer: single institutional experience

432 Hyperthermic intraperitoneal chemotherapy for treatment of ovarian and primary peritoneal cancer: single institutional experience

432
Hyperthermic intraperitoneal chemotherapy for treatment of ovarian and primary peritoneal cancer: single institutional experience